MÄNNEDORF, Switzerland--(BUSINESS WIRE)-- Tecan, the global leader in laboratory automation, today announced the unveiling of Veya™, a transformative liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes. The platform, showcased at the Society for Laboratory Automation and Screening (SLAS) international conference, San Diego, underscores Tecan’s continued commitment to innovation and the democratization of lab automation. Veya overcomes key barriers in lab automation by offering an accessible and versatile platform that streamlines compl...
28 October could mark a crucial step forward in the resolution of the asbestos litigation. The hearing set on this date at the Delaware court could lead to the launch of the plaintiffs’ vote on the reorganisation plan (agreement if 75% of plaintiffs vote in favour of the plan). We think that this vote is highly likely to materialise, notably with the integration of J&J into the plan (hearing of 8 October). The intrinsic valuation of the group’s assets (TQC, the Beauvoir/Saint-Austell ...
Le 28 octobre prochain pourrait marquer une avancée cruciale dans la résolution des litiges amiante. L’audience prévue pour cette date dans l’agenda du tribunal du Delaware pourrait conduire au lancement du vote des plaignants sur le plan de réorganisation (accord si 75% des plaignants votent le plan). Nous pensons que ce vote a de grandes chances d’aboutir avec l’intégration de J&J dans le plan (décision du 8 octobre dernier). La valorisation intrinsèque des actifs du groupe reviendr...
>CMD provided a deep insight into Tecan’s attractive product portfolio - During the CMD, Tecan's focus was clearly on the attractiveness of its product portfolio and in particular on the presentation of the new Veya platform. Questions from analysts and investors centred more on the reasons for last week's profit warning, on which the company provided some further details but no real new insights. The difficult market environment in China, in which Tecan is involved w...
We measured the impact of the contribution from Michel Barnier’s exceptional tax on 88 stocks exposed to France. Some 17 of them would experience a (negative) impact on their EPS of more than 4% on average over 2024 and 2025: LDC (-8.3%), Synergie (-8%), Eiffage (-7.9%), ADP (-7.9%), Dassault Aviation (-7%), Crit (-6.9%), Derichebourg (-6.3%), Hermès (-5.6%), Safran (-5.6%), Bouygues (-5.6%), M6 (-5.2%), Thales (-5%), TF1 (-4.9%), Nexans (-4.9%), Vinci (-4.7%), Compagnie des Alpes (...
Nous avons mesuré l’impact de la contribution exceptionnelle Barnier sur 88 valeurs exposées à la France. 17 d’entre elles auraient un impact (négatif) sur leurs BPA de plus de 4% en moyenne sur 2024 et 2025 : LDC (-8,3%), Synergie (-8%), Eiffage (-7,9%) ADP (-7,9%), Dassault Aviation (-7%), Crit (-6,9%), Derichebourg (-6,3%), Hermès (-5,6%), Safran (-5,6%), Bouygues (-5,6%), M6 (-5,2%), Thalès (-5%), TF1 (-4,9%), Nexans (-4,9%), Vinci (-4,7%), Compagnie des Alpes (-4,4%), FDJ (-4%). - ...
>Second profit warning within two months - After Tecan cut its 2024 guidance already on 13 August, the company published a further profit warning for FY 2024 on 16 October following a disappointing trading update. Since the release of its H1 2024 figures, Tecan has experienced a weak operating performance in both reporting divisions. In the Partnering Business customers for life sciences-related instruments and those with considerable exposure to the Chinese market ha...
We initiate coverage of Tecan with a TP of CHF 328 and an Outperform rating. As a leading developer and manufacturer of automated laboratory instruments and solutions, Tecan benefits from the rapidly growing trends in the healthcare industry. By focusing on attractive growth segments such as genomics, proteomics and cell & tissue analysis, Tecan should continue to organically outperform the growth of its industry (6.5% revenue CAGR until 2030 vs 3-5% p.a. for the industry). Owing...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.